CLINICAL RESEARCH IN STEM CELL TRANSPLANTATION
干细胞移植的临床研究
基本信息
- 批准号:6045410
- 负责人:
- 金额:$ 12.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-14 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:autologous transplantation breast neoplasms carmustine cis platinum compound clinical research clinical trial phase I cyclophosphamide homologous transplantation human subject human therapy evaluation metastasis neoplasm /cancer chemotherapy neoplasm /cancer immunotherapy radionuclides stem cell transplantation yttrium
项目摘要
The ongoing work and the proposed studies described in this
application have, as a common theme, the use of immunotherapy as an adjunct to
high-dose chemotherapy for patients with advanced or high-risk primary breast
cancer. Three feasibility studies are described which form the basis for the
proposed clinical trials, two of which are phase II and one of which is a
randomized study. A retrospective analysis performed by Dr. Bearman's fellow,
Dr. Yago Nieto, has resulted in the development of a model to predict patients
with high-risk primary breast cancer who are at high-risk of relapse after
autologous transplant. That model will identify candidates for two of the
proposed clinical trials. This application also describes how Dr. Bearman
will trainee young investigators in patient-oriented research. The UCHSC Bone
Marrow Transplant Program has sufficient patients to conduct these studies,
actively conducts both laboratory and clinical research, and is funded by both
peer-reviewed and pharmaceutical support. Dr. Bearman will devote 50 percent
effort to this 5 year program.
正在进行的工作和拟议的研究中所描述的,
作为一个共同的主题,使用免疫疗法作为一种辅助手段,
晚期或高危原发性乳腺癌大剂量化疗
癌 三个可行性研究的描述,形成的基础上,
拟议的临床试验,其中两个是第二阶段,其中一个是
随机研究。 Bearman博士的同事进行了一项回顾性分析,
亚戈·涅托博士,已经导致了一个模型的发展,以预测病人
患有高风险原发性乳腺癌的患者,
自体移植 该模型将确定两个候选人,
拟进行临床试验。 该应用程序还描述了比尔曼博士如何
将培训年轻的研究人员进行以病人为中心的研究。 UCHSC Bone
骨髓移植计划有足够的患者进行这些研究,
积极进行实验室和临床研究,并由双方资助
同行评审和药物支持。 比尔曼博士会拿出50%
为这个五年计划而努力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT I BEARMAN其他文献
SCOTT I BEARMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT I BEARMAN', 18)}}的其他基金
ALLOGENEIC LEUKOCYTE INFUSIONS FOR BREAST CANCER
同种异体白细胞输注治疗乳腺癌
- 批准号:
2885536 - 财政年份:1999
- 资助金额:
$ 12.53万 - 项目类别:
相似海外基金
Pathology of Breast Neoplasms determined by MRS
MRS 测定乳腺肿瘤的病理学
- 批准号:
nhmrc : 950215 - 财政年份:1995
- 资助金额:
$ 12.53万 - 项目类别:
NHMRC Project Grants